生物工程外细胞囊泡水凝调节炎症微环境用于伤口管理.
Yunfei Mu1, Liwen Ma2, Jia Yao1
1State Key Laboratory of Organic Electronics and Information Displays, Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Nanjing University of Posts and Telecommunications, Nanjing 210023, China.
International journal of molecular sciences
|December 17, 2024
概括
这项研究引入了一种新的生物活性水凝贴片,用于慢性伤口愈合. 该贴片使用工程外细胞囊泡来减少炎症并促进组织再生,改善愈合结果.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 免疫学 免疫学 免疫学
背景情况:
- 由于持续的炎症,感染风险和有限的治疗选择,慢性伤口带来了重大挑战.
- 有效的伤口管理需要解决生物愈合环境和后勤应用的策略.
研究的目的:
- 开发一种新的生物活性水凝贴片,以增强慢性伤口愈合.
- 在水凝基质中研究工程外细胞囊泡的免疫调节和再生能力.
主要方法:
- 合成了ZIF@EV纳米颗粒,通过封装西奥利性伊米达酸框架-8 (ZIF-8) 进入M2巨细胞衍生的细胞外囊泡 (EV).
- 将ZIF@EV纳米颗粒嵌入甲基酸盐凝矩阵中,以创建一个生物活性凝贴片.
- 在慢性伤口的小鼠模型中评估了水凝贴片的疗效,并将其与生长因子疗法和泡敷料进行了比较.
主要成果:
- 水凝贴片促进了治疗剂的控制释放,刺激了内皮细胞的增殖和血管生成.
- 用EV注入的贴片成功将巨细胞两极化为M2表型,将伤口微环境转向再生.
- 与传统治疗相比,在愈合速度,质量和组织整合方面表现出显著的改善.
结论:
- 开发的生物活性水凝贴片为治疗慢性伤口提供了一个有希望的,多功能和实用的解决方案.
- 这种可适应的平台解决了慢性伤口护理的关键生物和临床需求.
- 这种生物工程方法的进一步临床转化有可能改善患者的治疗结果.
相关概念视频
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.7K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K